Teva Unit Marketed Opioid For Off-Label Uses, Judge Hears
By Bonnie Eslinger · May 17, 2022, 11:42 PM EDT
Teva unit Cephalon saw sales of its opioid lollipop Actiq soar after it began marketing the product for non-FDA approved off-label uses, a judge heard Tuesday in recorded testimony from ex-Cephalon...
To view the full article, register now.